Inhibikase Therapeutics (IKT) Capital Leases (2022 - 2024)
Inhibikase Therapeutics' (IKT) quarterly Capital Leases came in at $58330.0 in Q1 2024, down 67.25% year-on-year from $178110.0 in Q2 2023, and down 35.28% on a QoQ basis from $90124.0 in Q4 2023.
Inhibikase Therapeutics (IKT) Capital Leases (2022 - 2024) Analysis & Trends
Inhibikase Therapeutics (IKT) has 3 years of Capital Leases data on file, last reported at $58330.0 in Q1 2024.
- On a quarterly basis, Capital Leases fell 67.25% year-over-year to $58330.0 in Q1 2024; TTM through Mar 2024 was $58330.0, a 67.25% decrease from a year earlier, with the FY2023 full-year figure at $90124.0, down 56.13% from the prior year.
- Capital Leases for Q1 2024 stood at $58330.0, down from $90124.0 in the prior quarter.
- Over the last five years, Capital Leases for IKT reached as high as $232020.0 in Q3 2022 and fell as low as $58330.0 in Q1 2024.
- Historically, Capital Leases has averaged $147859.9 across 3 years, with a median of $149971.0 in 2023.
- Across the five-year window, Capital Leases tumbled 47.84% in 2023 and tumbled 67.25% in 2024, its largest moves.
- Year by year, Capital Leases stood at $205451.0 in 2022, then plunged by 56.13% to $90124.0 in 2023, then slumped by 35.28% to $58330.0 in 2024.
- Per Business Quant data, the three most recent Capital Leases figures were $58330.0 in Q1 2024, $90124.0 in Q4 2023, and $121013.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inhibikase Therapeutics | 55.25 Mn | -115.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 58,330.00 |
| Dec 31, 2023 | 90,124.00 |
| Sep 30, 2023 | 121,013.00 |
| Jun 30, 2023 | 149,971.00 |
| Mar 31, 2023 | 178,110.00 |
| Dec 31, 2022 | 205,451.00 |
| Sep 30, 2022 | 232,020.00 |